Cargando…
Tocilizumab in the treatment of mixed connective tissue disease and overlap syndrome in children
Arthritis is one of the main manifestations of mixed connective tissue disease (MCTD) and overlap syndrome in children and can be responsible for functional disability. We report on 2 children with arthritis that were dramatically improved by a treatment with interleukin-6 (IL-6) blockers in the con...
Autores principales: | Cabrera, Natalia, Duquesne, Agnes, Desjonquères, Marine, Larbre, Jean-Paul, Lega, Jean-Christophe, Fabien, Nicole, Belot, Alexandre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030575/ https://www.ncbi.nlm.nih.gov/pubmed/27738519 http://dx.doi.org/10.1136/rmdopen-2016-000271 |
Ejemplares similares
-
Tocilizumab for the treatment of refractory pediatric mixed connective tissue disease (MCTD), in two patients
por: Cabrera, Natalia, et al.
Publicado: (2014) -
Growing up with chronic arthritis: the confusing matter of classification
por: Guillaume-Czitrom, Séverine, et al.
Publicado: (2017) -
Autoamputation and Polyneuropathy in Mixed Connective Tissue Disorder: A Case Report
por: Naqvi, Syeda, et al.
Publicado: (2017) -
Mixed Connective Tissue Disorder Complicated by Polymyositis, Sjogren’s Syndrome, Pleural Effusion and Pericarditis
por: Kundi, Maryam, et al.
Publicado: (2016) -
Tocilizumab in Large Vessel Vasculitis – Different Routes of Administration
por: Schmalzing, Marc, et al.
Publicado: (2018)